Biocartis: Anthony Sireci, Maria Arcila
Biocartis has appointed a new medical advisory board, effective Aug. 28. The first two members are Anthony "Nino" Sireci and Maria Arcila. Additional members will join in the coming weeks.
Sireci, a board-certified clinical pathologist and a practicing molecular pathologist, currently serves as senior VP of diagnostics development at Loxo Oncology at Lilly. Prior to joining Loxo, Sireci was a professor of pathology at Columbia University and medical director in the Laboratory of Personalized Genomic Medicine at Columbia Medical Center. He is a member of the pathology coding caucus in the College of American Pathologists and the molecular pathology advisory group in the American Medical Association.
Arcila has served as director of the molecular pathology laboratory at Memorial Sloan Kettering Cancer Center and is currently the deputy chief of the molecular diagnostic service. Her research highlights therapeutic and prognostic molecular markers in solid tumors and hematologic malignancies and focuses on the expansion, validation, and implementation of clinical tests to optimize precision medicine.